𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New steroids for inflammatory bowel disease

✍ Scribed by Dr. Robert Löfberg

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
700 KB
Volume
1
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis

The antiinflammatory effects of glucocorticosteroids (GCS) in inflammatory bowel disease (IBD) are unsurpassed by those of any other type of drug, but the beneficial effects are often offset by troublesome, and sometimes irreversible, systemic side effects. Improved GCS have been developed with the aim of obtaining improved topical action, with reduced systemic side effects.

📜 SIMILAR VOLUMES

Inflammatory Bowel Disease
Inflammatory Bowel Disease
✍ Aravind Suppiah; Jonathon Cowley; Chris Macklin 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 144 KB
New pathogenic paradigms in inflammatory
New pathogenic paradigms in inflammatory bowel disease
✍ Antonio Di Sabatino; Paolo Biancheri; Laura Rovedatti; Thomas T. MacDonald; Gino 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Recent progresses in basic science have opened new pathogenic scenarios in inflammatory bowel disease. The T helper cell type (Th)1/Th2 paradigm has been outdated thanks to the advances in understanding the function of Th17 cells. Innate immunity, nonimmune cells, and defective tolerogenic mechanism